Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs

The contract research organization consolidation trend continues with Worldwide Clinical Trials striking a deal for Catalyst Clinical Research, which has particular expertise in oncology. Worldwide is a portfolio company of Kohlberg, a private equity firm. The post Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs appeared first on MedCity News.

Read More

Weekend Links

Life science options for commercialization success.There were fewer births in China in 2025 than in 1776.The end of vaccine development?“Medicare Part D led to a slower increase in AMR-related inpatient discharges”Is mobility the missing quality measure?

Read More

Same Mutation, Different Fate

When MRD testing evolves from a numerical readout into a definition of clonal behavior, it becomes what clinicians have needed all along: a tool that informs action, not just detection. The post Same Mutation, Different Fate appeared first on MedCity News.

Read More